Intravitreal Triamcinolone Acetonide Treatment for Serpiginous Choroiditis

Purpose: To report the efficacy of intravitreal triamcinolone acetonide injection for acute treatment of a patient with serpiginous choroiditis. Methods: A 50-year-old male patient with serpiginous choroiditis presenting with the complaint of decreased visual acuity in his right eye for the last 10...

Full description

Saved in:
Bibliographic Details
Published in:Ocular immunology and inflammation 2006-12, Vol.14 (6), p.375-378
Main Authors: Ad güzel, Ufuk, Sar, Ayça, Özmen, Cengiz, Öz, Özay
Format: Article
Language:English
Subjects:
Choroiditis - drug therapy
Choroiditis - pathology
Fluorescein Angiography
Fundus Oculi
Glucocorticoids - administration & dosage
Glucocorticoids - therapeutic use
Humans
Injections
intravitreal triamcinolone acetonide
Male
Middle Aged
Serpiginous choroiditis
Triamcinolone Acetonide - administration & dosage
Triamcinolone Acetonide - therapeutic use
Visual Acuity
Vitreous Body
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: To report the efficacy of intravitreal triamcinolone acetonide injection for acute treatment of a patient with serpiginous choroiditis. Methods: A 50-year-old male patient with serpiginous choroiditis presenting with the complaint of decreased visual acuity in his right eye for the last 10 days. The best corrected visual acuity (BCVA) of the patient was counting finger from 1 meter. Fundus examination and fundus fluorescein angiography of right eye revealed active macular choroiditis in right eye. Intravitreal triamcinolone acetonide (4 mg/0.1 ml) was injected into vitreous, and the patient was followed with visual acuity testing, intraocular pressure measurement, and fundus examination, including fundus fluorescein angiography. Results: Visual acuity of the patient improved to 20/100 after 2 weeks in spite of the triamcinolone crystals, and to 20/50 after 4 weeks with a single dose intravitreal triamcinolone acetonide injection. Complete resolution of the active lesion has been maintained during the 6 months of follow-up. Conclusions: Single dose intravitreal triamcinolone acetonide injection is sufficient for controlling the active lesions in serpiginous choroiditis. It needs further evaluation as an alternative treatment for achieving rapid and significant visual acuity recovery.
ISSN:0927-3948
1744-5078
DOI:10.1080/09273940601025974